First-time hypnotic dispensing fell during the first Dutch COVID-19 lockdown, but the data did not establish that sleep problems became less common.
What the source reports
Pharmacy records covering approximately 96% of dispensations compared early 2020 with corresponding 2019 periods. First-time dispensing meant no hypnotic in the preceding year. The category included benzodiazepines, related hypnotics and other sleep medicines. Counts were lower overall, with age- and sex-specific differences; the elderly did not show the same significant lockdown reduction.
Limits and uncertainty
The measure concerns dispensing and access, rather than symptom prevalence or confirmed ingestion. Over-the-counter remedies and untreated sleep complaints were unavailable. A one-year lookback does not guarantee lifetime first use, and the grouped drug category should not be presented as benzodiazepines alone.
Implications for forensic review
When interpreting a change in prescribing, consider disrupted appointments, access and self-treatment alongside clinical need. Reduced dispensing is not evidence of reduced insomnia or improved safety. The study provides a historical service-use observation whose meaning depends on what happened outside the prescription database.
Source and related reading
Source reviewed: The Number of Newly Dispensed Hypnotic Drugs During the First COVID 19 Lockdown Period in The Nether (PMC13003303). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: A Sleep Formulary Changed Prescribing Systems Alongside Medication Choice.
Leave a Reply